Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 48 of 56 entries
Sorted by: Best Match Show Resources per page
Upcoming ISSX Meetings.

Drug metabolism reviews

[No authors listed]
PMID: 27418301
Drug Metab Rev. 2016 Jul;48:5. doi: 10.1080/03602532.2016.1191849.

No abstract available.

Cite
Upcoming ISSX Meetings. Drug Metab Rev. 2016;48:5doi: 10.1080/03602532.2016.1191849.
(2016). Upcoming ISSX Meetings. Drug metabolism reviews, 485. https://doi.org/10.1080/03602532.2016.1191849
"Upcoming ISSX Meetings." Drug metabolism reviews vol. 48 (2016): 5. doi: https://doi.org/10.1080/03602532.2016.1191849
Upcoming ISSX Meetings. Drug Metab Rev. 2016 Jul;48:5. doi: 10.1080/03602532.2016.1191849. PMID: 27418301.
Copy Download .nbib Format: NLM
Prediction of drug-induced kidney injury in drug discovery.

Drug metabolism reviews

Kulkarni P.
PMID: 34000943
Drug Metab Rev. 2021 May;53(2):234-244. doi: 10.1080/03602532.2021.1922436. Epub 2021 May 17.

Drug induced kidney injury is one of the leading causes of failure of drug development programs in the clinic. Early prediction of renal toxicity potential of drugs is crucial to the success of drug candidates in the clinic. The...

Cite
Kulkarni P. Prediction of drug-induced kidney injury in drug discovery. Drug Metab Rev. 2021;53(2):234-244doi: 10.1080/03602532.2021.1922436.
Kulkarni, P. (2021). Prediction of drug-induced kidney injury in drug discovery. Drug metabolism reviews, 53(2), 234-244. https://doi.org/10.1080/03602532.2021.1922436
Kulkarni, Priyanka. "Prediction of drug-induced kidney injury in drug discovery." Drug metabolism reviews vol. 53,2 (2021): 234-244. doi: https://doi.org/10.1080/03602532.2021.1922436
Kulkarni P. Prediction of drug-induced kidney injury in drug discovery. Drug Metab Rev. 2021 May;53(2):234-244. doi: 10.1080/03602532.2021.1922436. Epub 2021 May 17. PMID: 34000943.
Copy Download .nbib Format: NLM
Validation of the performance of a comprehensive genotyping assay panel of single nucleotide polymorphisms in drug metabolism enzyme genes.

Human mutation

Welch RA, Lazaruk K, Haque KA, Hyland F, Xiao N, Wronka L, Burdett L, Chanock SJ, Ingber D, De La Vega FM, Yeager M.
PMID: 18327779
Hum Mutat. 2008 May;29(5):750-6. doi: 10.1002/humu.20703.

A class of genes, known as drug metabolism enzymes (DMEs) are responsible for the metabolism and transport of drugs and other xenobiotics. Variation in DME genes most likely accounts for a proportion of the variability in drug response in...

Cite
Welch RA, Lazaruk K, Haque KA, et al. Validation of the performance of a comprehensive genotyping assay panel of single nucleotide polymorphisms in drug metabolism enzyme genes. Hum Mutat. 2008;29(5):750-6doi: 10.1002/humu.20703.
Welch, R. A., Lazaruk, K., Haque, K. A., Hyland, F., Xiao, N., Wronka, L., Burdett, L., Chanock, S. J., Ingber, D., De La Vega, F. M., & Yeager, M. (2008). Validation of the performance of a comprehensive genotyping assay panel of single nucleotide polymorphisms in drug metabolism enzyme genes. Human mutation, 29(5), 750-6. https://doi.org/10.1002/humu.20703
Welch, Robert A, et al. "Validation of the performance of a comprehensive genotyping assay panel of single nucleotide polymorphisms in drug metabolism enzyme genes." Human mutation vol. 29,5 (2008): 750-6. doi: https://doi.org/10.1002/humu.20703
Welch RA, Lazaruk K, Haque KA, Hyland F, Xiao N, Wronka L, Burdett L, Chanock SJ, Ingber D, De La Vega FM, Yeager M. Validation of the performance of a comprehensive genotyping assay panel of single nucleotide polymorphisms in drug metabolism enzyme genes. Hum Mutat. 2008 May;29(5):750-6. doi: 10.1002/humu.20703. PMID: 18327779.
Copy Download .nbib Format: NLM
20th North American ISSX Meeting 18-22 October 2015Orlando, Florida, USA.

Drug metabolism reviews

[No authors listed]
PMID: 27418299
Drug Metab Rev. 2016 Jul;48:2-3. doi: 10.1080/03602532.2016.1191846.

No abstract available.

Cite
20th North American ISSX Meeting 18-22 October 2015Orlando, Florida, USA. Drug Metab Rev. 2016;48:2-3doi: 10.1080/03602532.2016.1191846.
(2016). 20th North American ISSX Meeting 18-22 October 2015Orlando, Florida, USA. Drug metabolism reviews, 482-3. https://doi.org/10.1080/03602532.2016.1191846
"20th North American ISSX Meeting 18-22 October 2015Orlando, Florida, USA." Drug metabolism reviews vol. 48 (2016): 2-3. doi: https://doi.org/10.1080/03602532.2016.1191846
20th North American ISSX Meeting 18-22 October 2015Orlando, Florida, USA. Drug Metab Rev. 2016 Jul;48:2-3. doi: 10.1080/03602532.2016.1191846. PMID: 27418299.
Copy Download .nbib Format: NLM
20th North American ISSX Meeting.

Drug metabolism reviews

[No authors listed]
PMID: 27418305
Drug Metab Rev. 2016 Jul;48:158-64. doi: 10.1080/03602532.2016.1191841.

No abstract available.

Cite
20th North American ISSX Meeting. Drug Metab Rev. 2016;48:158-64doi: 10.1080/03602532.2016.1191841.
(2016). 20th North American ISSX Meeting. Drug metabolism reviews, 48158-64. https://doi.org/10.1080/03602532.2016.1191841
"20th North American ISSX Meeting." Drug metabolism reviews vol. 48 (2016): 158-64. doi: https://doi.org/10.1080/03602532.2016.1191841
20th North American ISSX Meeting. Drug Metab Rev. 2016 Jul;48:158-64. doi: 10.1080/03602532.2016.1191841. PMID: 27418305.
Copy Download .nbib Format: NLM
Abstracts from the 19th North American ISSX and 29th JSSX Meeting.

Drug metabolism reviews

[No authors listed]
PMID: 26247907
Drug Metab Rev. 2015;47:1. doi: 10.3109/03602532.2015.1071937. Epub 2015 Oct 02.

No abstract available.

Cite
Abstracts from the 19th North American ISSX and 29th JSSX Meeting. Drug Metab Rev. 2015;47:1doi: 10.3109/03602532.2015.1071937.
(2015). Abstracts from the 19th North American ISSX and 29th JSSX Meeting. Drug metabolism reviews, 471. https://doi.org/10.3109/03602532.2015.1071937
"Abstracts from the 19th North American ISSX and 29th JSSX Meeting." Drug metabolism reviews vol. 47 (2015): 1. doi: https://doi.org/10.3109/03602532.2015.1071937
Abstracts from the 19th North American ISSX and 29th JSSX Meeting. Drug Metab Rev. 2015;47:1. doi: 10.3109/03602532.2015.1071937. Epub 2015 Oct 02. PMID: 26247907.
Copy Download .nbib Format: NLM
Abstracts from the DMW/ISSX 2000 Meeting.

Drug metabolism reviews

[No authors listed]
PMID: 28256155
Drug Metab Rev. 2000 Dec;32:vii-120. doi: 10.1080/03602532.2000.11864614.

No abstract available.

Cite
Abstracts from the DMW/ISSX 2000 Meeting. Drug Metab Rev. 2000;32:vii-120doi: 10.1080/03602532.2000.11864614.
(2000). Abstracts from the DMW/ISSX 2000 Meeting. Drug metabolism reviews, 32vii-120. https://doi.org/10.1080/03602532.2000.11864614
"Abstracts from the DMW/ISSX 2000 Meeting." Drug metabolism reviews vol. 32 (2000): vii-120. doi: https://doi.org/10.1080/03602532.2000.11864614
Abstracts from the DMW/ISSX 2000 Meeting. Drug Metab Rev. 2000 Dec;32:vii-120. doi: 10.1080/03602532.2000.11864614. PMID: 28256155.
Copy Download .nbib Format: NLM
Cytochrome P450 expression and regulation in the brain.

Drug metabolism reviews

Kuban W, Daniel WA.
PMID: 33356626
Drug Metab Rev. 2021 Feb;53(1):1-29. doi: 10.1080/03602532.2020.1858856. Epub 2020 Dec 27.

The regulation of brain cytochrome P450 enzymes (CYPs) is different compared with respective hepatic enzymes. This may result from anatomical bases and physiological functions of the two organs. The brain is composed of a variety of functional structures built...

Cite
Kuban W, Daniel WA. Cytochrome P450 expression and regulation in the brain. Drug Metab Rev. 2020;53(1):1-29doi: 10.1080/03602532.2020.1858856.
Kuban, W., & Daniel, W. A. (2021). Cytochrome P450 expression and regulation in the brain. Drug metabolism reviews, 53(1), 1-29. https://doi.org/10.1080/03602532.2020.1858856
Kuban, Wojciech, and Daniel, Władysława Anna. "Cytochrome P450 expression and regulation in the brain." Drug metabolism reviews vol. 53,1 (2021): 1-29. doi: https://doi.org/10.1080/03602532.2020.1858856
Kuban W, Daniel WA. Cytochrome P450 expression and regulation in the brain. Drug Metab Rev. 2021 Feb;53(1):1-29. doi: 10.1080/03602532.2020.1858856. Epub 2020 Dec 27. PMID: 33356626.
Copy Download .nbib Format: NLM
Drug metabolic stability in early drug discovery to develop potential lead compounds.

Drug metabolism reviews

Gajula SNR, Nadimpalli N, Sonti R.
PMID: 34406889
Drug Metab Rev. 2021 Aug;53(3):459-477. doi: 10.1080/03602532.2021.1970178. Epub 2021 Sep 11.

Knowledge of the metabolic stability of a new drug substance eliminated by biotransformation is essential for envisaging the pharmacokinetic parameters required for deciding drug dosing and frequency. Strategies aimed at modifying lead compounds may improve metabolic stability, thereby reducing...

Cite
Gajula SNR, Nadimpalli N, Sonti R. Drug metabolic stability in early drug discovery to develop potential lead compounds. Drug Metab Rev. 2021;53(3):459-477doi: 10.1080/03602532.2021.1970178.
Gajula, S. N. R., Nadimpalli, N., & Sonti, R. (2021). Drug metabolic stability in early drug discovery to develop potential lead compounds. Drug metabolism reviews, 53(3), 459-477. https://doi.org/10.1080/03602532.2021.1970178
Gajula, Siva Nageswara Rao, et al. "Drug metabolic stability in early drug discovery to develop potential lead compounds." Drug metabolism reviews vol. 53,3 (2021): 459-477. doi: https://doi.org/10.1080/03602532.2021.1970178
Gajula SNR, Nadimpalli N, Sonti R. Drug metabolic stability in early drug discovery to develop potential lead compounds. Drug Metab Rev. 2021 Aug;53(3):459-477. doi: 10.1080/03602532.2021.1970178. Epub 2021 Sep 11. PMID: 34406889.
Copy Download .nbib Format: NLM
Correction.

Drug metabolism reviews

[No authors listed]
PMID: 33781132
Drug Metab Rev. 2021 Feb;53(1):I-VI. doi: 10.1080/03602532.2021.1907078. Epub 2021 Mar 29.

No abstract available.

Cite
Correction. Drug Metab Rev. 2021;53(1):I-VIdoi: 10.1080/03602532.2021.1907078.
(2021). Correction. Drug metabolism reviews, 53(1), I-VI. https://doi.org/10.1080/03602532.2021.1907078
"Correction." Drug metabolism reviews vol. 53,1 (2021): I-VI. doi: https://doi.org/10.1080/03602532.2021.1907078
Correction. Drug Metab Rev. 2021 Feb;53(1):I-VI. doi: 10.1080/03602532.2021.1907078. Epub 2021 Mar 29. PMID: 33781132.
Copy Download .nbib Format: NLM
Rodent genetic models of Ah receptor signaling.

Drug metabolism reviews

Wilson RH, Bradfield CA.
PMID: 34289754
Drug Metab Rev. 2021 Aug;53(3):350-374. doi: 10.1080/03602532.2021.1955916. Epub 2021 Aug 25.

The aryl hydrocarbon receptor (AHR) is a ligand activated transcription factor that is a member of the PER-ARNT-SIM superfamily of environmental sensors. This receptor has been a molecule of interest for many years in the field of toxicology, as...

Cite
Wilson RH, Bradfield CA. Rodent genetic models of Ah receptor signaling. Drug Metab Rev. 2021;53(3):350-374doi: 10.1080/03602532.2021.1955916.
Wilson, R. H., & Bradfield, C. A. (2021). Rodent genetic models of Ah receptor signaling. Drug metabolism reviews, 53(3), 350-374. https://doi.org/10.1080/03602532.2021.1955916
Wilson, Rachel H, and Bradfield, Christopher A. "Rodent genetic models of Ah receptor signaling." Drug metabolism reviews vol. 53,3 (2021): 350-374. doi: https://doi.org/10.1080/03602532.2021.1955916
Wilson RH, Bradfield CA. Rodent genetic models of Ah receptor signaling. Drug Metab Rev. 2021 Aug;53(3):350-374. doi: 10.1080/03602532.2021.1955916. Epub 2021 Aug 25. PMID: 34289754.
Copy Download .nbib Format: NLM
Abstracts from the 10th North American ISSX Meeting.

Drug metabolism reviews

[No authors listed]
PMID: 28256160
Drug Metab Rev. 2000 Dec;32:vi-340. doi: 10.1080/03602532.2000.11864616.

No abstract available.

Cite
Abstracts from the 10th North American ISSX Meeting. Drug Metab Rev. 2000;32:vi-340doi: 10.1080/03602532.2000.11864616.
(2000). Abstracts from the 10th North American ISSX Meeting. Drug metabolism reviews, 32vi-340. https://doi.org/10.1080/03602532.2000.11864616
"Abstracts from the 10th North American ISSX Meeting." Drug metabolism reviews vol. 32 (2000): vi-340. doi: https://doi.org/10.1080/03602532.2000.11864616
Abstracts from the 10th North American ISSX Meeting. Drug Metab Rev. 2000 Dec;32:vi-340. doi: 10.1080/03602532.2000.11864616. PMID: 28256160.
Copy Download .nbib Format: NLM
Showing 37 to 48 of 56 entries